- Home
- ALLR vs ASBP Comparison
ALLR vs ASBP Comparison
Compare ALLR & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- ASBP
- Stock Information
- Founded
- ALLR 2004
- ASBP 2021
- Country
- ALLR United States
- ASBP United States
- Employees
- ALLR N/A
- ASBP N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- ASBP Biotechnology: Pharmaceutical Preparations
- Sector
- ALLR Health Care
- ASBP Health Care
- Exchange
- ALLR Nasdaq
- ASBP Nasdaq
- Market Cap
- ALLR 13.3M
- ASBP 11.9M
- IPO Year
- ALLR N/A
- ASBP N/A
- Fundamental
- Price
- ALLR $1.00
- ASBP $0.28
- Analyst Decision
- ALLR
- ASBP
- Analyst Count
- ALLR 0
- ASBP 0
- Target Price
- ALLR N/A
- ASBP N/A
- AVG Volume (30 Days)
- ALLR 464.0K
- ASBP 4.2M
- Earning Date
- ALLR 08-04-2025
- ASBP 08-24-2025
- Dividend Yield
- ALLR N/A
- ASBP N/A
- EPS Growth
- ALLR N/A
- ASBP N/A
- EPS
- ALLR N/A
- ASBP N/A
- Revenue
- ALLR N/A
- ASBP N/A
- Revenue This Year
- ALLR N/A
- ASBP N/A
- Revenue Next Year
- ALLR N/A
- ASBP N/A
- P/E Ratio
- ALLR N/A
- ASBP N/A
- Revenue Growth
- ALLR N/A
- ASBP N/A
- 52 Week Low
- ALLR $0.61
- ASBP $0.22
- 52 Week High
- ALLR $7.45
- ASBP $15.80
- Technical
- Relative Strength Index (RSI)
- ALLR 54.51
- ASBP N/A
- Support Level
- ALLR $0.80
- ASBP N/A
- Resistance Level
- ALLR $1.09
- ASBP N/A
- Average True Range (ATR)
- ALLR 0.07
- ASBP 0.00
- MACD
- ALLR 0.02
- ASBP 0.00
- Stochastic Oscillator
- ALLR 63.03
- ASBP 0.00
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.